“Efficacy of Apremilast on Quality-of-Life Measures in Patients With Moderate Plaque Psoriasis (UNVEIL Phase IV Study)”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s13, https://doi.org/10.25251/skin.1.supp.12.